NL8002071A - 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)- benzoee- zuurderivaten, werkwijze voor de bereiding daarvan, alsmede farmaceutische preparaten die deze bevatten. - Google Patents
2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)- benzoee- zuurderivaten, werkwijze voor de bereiding daarvan, alsmede farmaceutische preparaten die deze bevatten. Download PDFInfo
- Publication number
- NL8002071A NL8002071A NL8002071A NL8002071A NL8002071A NL 8002071 A NL8002071 A NL 8002071A NL 8002071 A NL8002071 A NL 8002071A NL 8002071 A NL8002071 A NL 8002071A NL 8002071 A NL8002071 A NL 8002071A
- Authority
- NL
- Netherlands
- Prior art keywords
- hydroxy
- ethyl
- piperazinyl
- methyl
- benzoic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3624479 | 1979-05-04 | ||
| US06/036,244 US4255575A (en) | 1979-05-04 | 1979-05-04 | 2-Hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzoic acid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8002071A true NL8002071A (nl) | 1980-11-06 |
Family
ID=21887503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8002071A NL8002071A (nl) | 1979-05-04 | 1980-04-09 | 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)- benzoee- zuurderivaten, werkwijze voor de bereiding daarvan, alsmede farmaceutische preparaten die deze bevatten. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4255575A (fr) |
| JP (1) | JPS55147262A (fr) |
| AT (1) | AT376426B (fr) |
| AU (1) | AU531738B2 (fr) |
| BE (1) | BE883086A (fr) |
| CA (1) | CA1138457A (fr) |
| CH (1) | CH645368A5 (fr) |
| DE (1) | DE3014813A1 (fr) |
| DK (1) | DK159435C (fr) |
| ES (1) | ES8104995A1 (fr) |
| FR (1) | FR2455590A1 (fr) |
| GB (1) | GB2053897B (fr) |
| IE (1) | IE49549B1 (fr) |
| IL (1) | IL59596A (fr) |
| IT (1) | IT1143190B (fr) |
| NL (1) | NL8002071A (fr) |
| NO (1) | NO152698C (fr) |
| NZ (1) | NZ193107A (fr) |
| PH (1) | PH17089A (fr) |
| SE (1) | SE447109B (fr) |
| ZA (1) | ZA801453B (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3400168A1 (de) * | 1984-01-04 | 1985-07-11 | Bayer Ag, 5090 Leverkusen | 5-halogenalkyl-1,3,4-thiadiazol-2-yloxyacetamide |
| US4616017A (en) * | 1984-06-04 | 1986-10-07 | Merck & Co., Inc. | Aminohydroxypropoxy substituted aryl compounds |
| DE3505425A1 (de) * | 1985-02-16 | 1986-08-21 | Bayer Ag, 5090 Leverkusen | 5-chlor-1,3,4-thiadiazol-2-yloxy-acetamide |
| GB8603120D0 (en) * | 1986-02-07 | 1986-03-12 | Pfizer Ltd | Anti-dysrhythmia agents |
| GB8609630D0 (en) * | 1986-04-19 | 1986-05-21 | Pfizer Ltd | Anti-arrhythmia agents |
| US4956302A (en) | 1987-09-11 | 1990-09-11 | Abbott Laboratories | Lateral flow chromatographic binding assay device |
| DE3812755A1 (de) * | 1988-04-16 | 1989-10-26 | Merck Patent Gmbh | Salicylsaeurederivate |
| KR100484386B1 (ko) * | 2000-10-04 | 2005-04-22 | 경동제약 주식회사 | 알킬2-[2,3,5-트리플루오로-4-(4-메틸-1-피페라지닐)]벤조일-3(ｓ)-(1-히드록시프로피-2-닐아미노)아크릴레이트의 제조방법 |
| US20080131954A1 (en) * | 2006-11-30 | 2008-06-05 | Canon U.S. Life Sciences, Inc. | Method of Separating Target DNA from Mixed DNA |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1317479A (en) * | 1970-11-10 | 1973-05-16 | Pfizer Ltd | 1-2-hydroxy-3-phenoxy or phenylthiopropyl-4-phenyl-piperazine derivatives |
| US4038279A (en) * | 1972-12-23 | 1977-07-26 | Boehringer Ingelheim Gmbh | N-aryl-n'-(phenyl-or phenoxy-alkyl)-piperazines and salts thereof |
| CA1113937A (fr) * | 1977-04-05 | 1981-12-08 | Frederic P. Hauck | Piperidinylpropanols substitues |
-
1979
- 1979-05-04 US US06/036,244 patent/US4255575A/en not_active Expired - Lifetime
-
1980
- 1980-03-10 IE IE481/80A patent/IE49549B1/en not_active IP Right Cessation
- 1980-03-12 ZA ZA00801453A patent/ZA801453B/xx unknown
- 1980-03-12 NZ NZ193107A patent/NZ193107A/xx unknown
- 1980-03-12 IL IL59596A patent/IL59596A/xx unknown
- 1980-03-21 PH PH23798A patent/PH17089A/en unknown
- 1980-03-26 IT IT48267/80A patent/IT1143190B/it active
- 1980-04-02 AU AU57076/80A patent/AU531738B2/en not_active Expired
- 1980-04-09 NL NL8002071A patent/NL8002071A/nl not_active Application Discontinuation
- 1980-04-17 CA CA000350105A patent/CA1138457A/fr not_active Expired
- 1980-04-17 ES ES490667A patent/ES8104995A1/es not_active Expired
- 1980-04-17 DE DE19803014813 patent/DE3014813A1/de not_active Withdrawn
- 1980-04-18 JP JP5054880A patent/JPS55147262A/ja active Granted
- 1980-04-22 CH CH309180A patent/CH645368A5/de not_active IP Right Cessation
- 1980-04-25 GB GB8013781A patent/GB2053897B/en not_active Expired
- 1980-04-29 SE SE8003244A patent/SE447109B/sv not_active IP Right Cessation
- 1980-04-30 AT AT0232580A patent/AT376426B/de not_active IP Right Cessation
- 1980-04-30 FR FR8009850A patent/FR2455590A1/fr active Granted
- 1980-05-01 DK DK193680A patent/DK159435C/da not_active IP Right Cessation
- 1980-05-02 NO NO801297A patent/NO152698C/no unknown
- 1980-05-02 BE BE0/200446A patent/BE883086A/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU5707680A (en) | 1980-11-06 |
| IL59596A (en) | 1984-01-31 |
| AU531738B2 (en) | 1983-09-01 |
| FR2455590B1 (fr) | 1983-10-14 |
| AT376426B (de) | 1984-11-26 |
| BE883086A (fr) | 1980-09-01 |
| DE3014813A1 (de) | 1980-11-13 |
| GB2053897B (en) | 1982-10-20 |
| FR2455590A1 (fr) | 1980-11-28 |
| US4255575A (en) | 1981-03-10 |
| IE49549B1 (en) | 1985-10-30 |
| NO801297L (no) | 1980-11-05 |
| DK159435C (da) | 1991-03-25 |
| IL59596A0 (en) | 1980-06-30 |
| DK193680A (da) | 1980-11-05 |
| ES490667A0 (es) | 1981-05-16 |
| SE8003244L (sv) | 1980-11-05 |
| JPS55147262A (en) | 1980-11-17 |
| NZ193107A (en) | 1982-12-21 |
| NO152698B (no) | 1985-07-29 |
| DK159435B (da) | 1990-10-15 |
| JPS6321666B2 (fr) | 1988-05-09 |
| ES8104995A1 (es) | 1981-05-16 |
| SE447109B (sv) | 1986-10-27 |
| IT8048267A0 (it) | 1980-03-26 |
| CA1138457A (fr) | 1982-12-28 |
| ATA232580A (de) | 1984-04-15 |
| IE800481L (en) | 1980-11-04 |
| CH645368A5 (de) | 1984-09-28 |
| GB2053897A (en) | 1981-02-11 |
| NO152698C (no) | 1985-11-20 |
| IT1143190B (it) | 1986-10-22 |
| ZA801453B (en) | 1980-12-31 |
| PH17089A (en) | 1984-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69815008T2 (de) | Alfa-substituierte Phenylpropionsäurederivate und diese enthaltende Arzneimittel | |
| US5206366A (en) | Process for preparing aryl piperazinyl-heterocyclic compounds | |
| JP2637737B2 (ja) | 新規な薬剤 | |
| FR2501690A1 (fr) | Derives heterocycliques du type 1,2,4-triazole, leur preparation et leur application pharmacologique | |
| JPH0647586B2 (ja) | １−ヘテロアリ−ル−４−〔（２．５−ピロリジンジオン−１−イル）アルキル〕ピペラジン誘導体 | |
| LU85442A1 (fr) | Agents antidepression a base de 1,2,4-triazol-3-one | |
| US5225409A (en) | Benzoxazinone compounds | |
| US5710152A (en) | Benzoazine derivative or salt thereof and pharmaceutical compostion comprising the same | |
| JPS6012350B2 (ja) | 新規アリ−ルピペリジン誘導体の製造方法 | |
| JPH0229671B2 (fr) | ||
| CA2087855A1 (fr) | Derives de substitution en 1 et 4 de piperazines | |
| FR2628425A1 (fr) | Derives d'isoindolinone, leurs procedes de preparation et les medicaments les contenant | |
| NL8002071A (nl) | 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)- benzoee- zuurderivaten, werkwijze voor de bereiding daarvan, alsmede farmaceutische preparaten die deze bevatten. | |
| US4337343A (en) | 4,5 or 6-Alkylaminoalkyl-2-alkyl-4,5,6,7-tetrahydro benzo[d]thiazoles | |
| DE69007837T2 (de) | Substituierte 1-[3-Heteroarylmethoxyphenyl]alkanole und verwandte Verbindungen, für die Behandlung von Asthma, Arthritis und ähnlichen Krankheiten. | |
| US5084456A (en) | Oxazolopyridine compounds | |
| KR0145337B1 (ko) | 의식장해 개선제, 중추신경계 부활제 또는 시그마 수용기 작동제용 카르보스티릴 유도체 및 이것을 함유하는 약학 조성물 | |
| PL179032B1 (pl) | kwasu hydroksamowego oraz kompozycje farmaceutyczne zawierajace nowe pochodnekwasu hydroksamowego PL PL | |
| SE446980B (sv) | Alkyltiofenoxialkylaminer samt forfarande for framstellning derav | |
| US4474783A (en) | Cyclopropylmethyl piperazines, the process for preparing the same and their use in therapeutics | |
| NL8203035A (nl) | Spirothiazolidinylpiperazinederivaten. | |
| JPH069588A (ja) | ピペラジン誘導体 | |
| EP0005091B1 (fr) | Nouvelles pipérazines monosubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant | |
| US4206217A (en) | 3-[4-(1,3-Diazacycloalken-2-yl)-phenyl]-1,2-benzisothiazoles, their manufacture, and drugs containing these compounds | |
| CH652119A5 (fr) | Derives de l'acide guanidinocyclohexanecarboxylique et leur procede de fabrication. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A85 | Still pending on 85-01-01 | ||
| BA | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| BV | The patent application has lapsed |